Health Science Council Subcommittee on Influenza Preparedness
Overview
This article summarizes meeting dates, agendas, and the availability of minutes and materials from the first meeting on April 21, 2015, through the joint meeting on October 14, 2026. Topics include stockpiling vaccines and antiviral drugs, revising the government action plan, vaccination procedures, and medical systems. The October 14, 2026, joint meeting lists support measures and legal frameworks based on the MCM strategy as an agenda item.
Key points
- Meeting records are listed from April 2015 through October 2026.
- Stockpiling policies and types of prepandemic vaccines have been agenda items at multiple meetings.
- Stockpiling and handling of anti-influenza virus drugs have also been discussed.
- The October 14, 2026, joint meeting lists support measures and legal frameworks based on the MCM strategy as an agenda item.
Overview
The listed information runs from the first meeting on April 21, 2015, through the joint meeting on October 14, 2026. The latest entry is listed as a joint meeting of the 27th Subcommittee and the 12th Subcommittee on Medical Countermeasures for Crisis Response.
Meeting agendas cover vaccine and anti-influenza virus drug stockpiles, vaccine development and effectiveness, revisions to the government action plan, vaccination, surveillance, and medical systems. The records include sections for minutes and summaries, materials, compliance-related materials, and meeting notices.
Details
Recent agendas include the future types of prepandemic vaccines to stockpile at the 26th meeting (April 23, 2026); the stockpiling policy for anti-influenza virus drugs and the effectiveness of pandemic vaccines at the 25th meeting (February 19, 2026); and the handling of those drugs at the 24th meeting (November 7, 2025).
Discussions on revising the government action plan took place on February 15 and March 8, 2024. The May 1 meeting covered the revision report, vaccine stockpile types, and development systems; the joint meeting on July 16 addressed revisions to the plan's guidelines.
Other agenda items include methods for estimating potential impacts, procedures for special-priority vaccination, procedures for resident vaccination, designated quarantine ports, medical equipment and supplies, pharmaceutical distribution, stockpile targets, and evaluation of cell-culture projects. Some meeting records show a dash (“-”) for minutes or materials.